Candel Therapeutics, Inc. Common Stock

CADL US1374041093

💰
Capitalization
Small-cap

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

🔗
Website
https://www.candeltx.com
Annual Performance 1
2021 2022 2023 2024 2025
12% -78% -17% 499% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
35
🙍
Insiders
6
Person Price Shares Total Published Completed
Nichols William Garrett
CMO 		6.98
USD 		937
Sold 		6,540
USD 		28/07/2025 28/07/2025
Nichols William Garrett
CMO 		5.04
USD 		781
Sold 		3,936
USD 		30/06/2025 30/06/2025
Nichols William Garrett
CMO 		5.04
USD 		781
Sold 		3,936
USD 		30/06/2025 30/06/2025
Tak Paul Peter
CEO 		9.00
USD 		400
Sold 		3,601
USD 		18/03/2025 19/03/2025
Tak Paul Peter
CEO 		8.77
USD 		25,772
Sold 		226,023
USD 		18/03/2025 18/03/2025
Barone Francesca
CSO 		8.76
USD 		32,146
Sold 		281,673
USD 		18/03/2025 18/03/2025
Nichols William Garrett
CMO 		8.76
USD 		45,316
Sold 		396,995
USD 		18/03/2025 18/03/2025
Schoch Charles
O 		8.83
USD 		5,000
Sold 		44,169
USD 		17/03/2025 17/03/2025
Tyagarajan Seshu
CTO 		8.82
USD 		31,278
Sold 		275,947
USD 		17/03/2025 17/03/2025
Barone Francesca
CSO 		7.23
USD 		13,534
Sold 		97,783
USD 		15/01/2025 15/01/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Candel Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
44% 32% 467% 423% 0% 0% 24%
Last 52W Low 52W High All-Time Low All-Time High β
5.63 3.80 12.21 0.68 14.00
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Manning Paul B 2 7,500,000.00 3,750,000.00 16/12/2024 16/12/2024
Tak Paul Peter 7 1,049,991.48 149,998.78 11/07/2024 19/03/2025
Nichols William Garrett 9 767,725.76 85,302.86 11/07/2024 28/07/2025
Tyagarajan Seshu 6 767,605.00 127,934.17 11/07/2024 17/03/2025
Barone Francesca 6 758,895.84 126,482.64 11/07/2024 18/03/2025
Schoch Charles 5 311,950.16 62,390.03 11/07/2024 17/03/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.